Phase I dose escalating trial of KOS-953 (heat shock protein 90 inhibitor) and trastuzumab (T) Meeting Abstract


Authors: Modi, S.; Stopeck, A. T.; Gordon, M. S.; Solit, D.; Bagatell, R.; Ma, W.; Wheler, J.; Cropp, G. F.; Rosen, N.; Johnson, R. G. Jr; Hannah, A. L.; Hudis, C.
Abstract Title: Phase I dose escalating trial of KOS-953 (heat shock protein 90 inhibitor) and trastuzumab (T)
Meeting Title: 97th Annual Meeting of the American Association for Cancer Research (AACR)
Keywords: dose escalation
Journal Title: Cancer Research
Volume: 66
Issue: 8 Suppl.
Meeting Dates: 2006 Apr 1-5
Meeting Location: Washington, DC
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2006-04-15
Start Page: 686
Language: English
ACCESSION: BIOSIS:PREV200600596915
PROVIDER: biosis
DOI/URL:
Notes: --- - Meeting Abstract: 2919 - In: Proceedings of the 97th Annual Meeting of the American Association for Cancer Research - Washington, DC, USA - April 01 -05, 2006 - Amer Assoc Canc Res - "Source: Biosis"
MSK Authors
  1. Jennifer Wheler
    11 Wheler
  2. Clifford Hudis
    905 Hudis
  3. Neal Rosen
    426 Rosen
  4. David Solit
    781 Solit
  5. Weining Ma
    40 Ma
  6. Shanu Modi
    268 Modi